glp-1 class drugs Agonists: A Comprehensive Overview Do The Benefits of GLP-1

Regular medical checks with a doctor, nurse practitioner, or physician assistant during the Active and Transition phases of the program

Pratt et al

Whats emerging here is a new paradigm where: neuronal energy metabolism becomes a therapeutic target

Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin-associated weight gain: 52-week results from the effect of liraglutide on insulin-associated weight gain in patients with type 2 diabetes (ELEGANT) randomized controlled trial

[DOI] [PubMed] [Google Scholar] 157.Guo L., Akahori H., Harari E., Smith S.L., Polavarapu R., Karmali V., Otsuka F., Gannon R.L., Braumann R.E., Dickinson M.H., et al

Several SURMOUNT studies in patients with obesity are ongoing ( In the SURPASS-1 study, which enrolled 705 non-target T2DM patients with diet and physical activity intervention, the efficacy, safety, and tolerability of tirzepatide and a placebo were compared